• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.40% Nasdaq Up0.19%

    Anika Therapeutics Inc. (ANIK)

    47.27 Down 0.11(0.24%) 11:52AM EDT - Nasdaq Real Time Price
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.0
    Mean Recommendation (last week):2.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:51.75
    Median Target:51.00
    High Target:60.00
    Low Target:45.00
    No. of Brokers:4

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    May 9, 2016Singular ResearchUpgradeBUY - Long-TermBuy
    Apr 27, 2016Northland CapitalDowngradeOutperformMarket Perform
    Oct 12, 2015Barrington ResearchInitiated Outperform
    Aug 28, 2015First Analysis SecInitiated Equal-Weight
    May 14, 2015Northland CapitalInitiated Outperform
    Aug 19, 2014Singular ResearchDowngradeBuyBUY - Long-Term
    May 8, 2007Susquehanna FinancialInitiated Neutral
    Jul 26, 2006Nollenberger CapitalUpgradeNeutralBuy
    Mar 3, 2006Nollenberger CapitalDowngradeBuyNeutral
    Jun 27, 2005First AlbanyDowngradeBuyNeutral

    More Upgrades & Downgrades for ANIK

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy2222

    Data provided by Thomson/First Call

    Currency in USD.